Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Dogwood Therapeutics, Inc (DWTX) had Non-Operating Income/Expense of $0.05M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-11.53M |
|
-- |
|
-- |
|
$14.06M |
|
$-14.06M |
|
|
Non-Operating Income/Expense |
$0.05M |
$-14.01M |
|
$-14.01M |
|
$-11.53M |
|
$-11.53M |
|
$-11.53M |
|
$-11.53M |
|
$-14.06M |
|
$-14.06M |
|
34.13M |
|
34.13M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$11.03M |
|
$0.01M |
|
$69.47M |
|
$80.50M |
|
$2.83M |
|
-- |
|
$9.30M |
|
$12.13M |
|
$68.37M |
|
$-0.94M |
|
$68.37M |
|
33.63M |
|
| Cash Flow Statement Financials | |
$-8.20M |
|
-- |
|
$11.29M |
|
$6.52M |
|
$9.61M |
|
$3.09M |
|
$0.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.86% |
|
1223.25% |
|
-14.32% |
|
-16.86% |
|
$2.03 |
|
$-0.24 |
|
$-0.24 |
|